(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-21 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 596614
| Date | Daily Closing Price | Open | High | Low | Volume |
| 21 Wed Aug 2024 | 94.78 | 93.73 | 95.85 | 93.26 | 0.754 times |
| 20 Tue Aug 2024 | 93.20 | 94.18 | 95.20 | 92.92 | 0.589 times |
| 19 Mon Aug 2024 | 95.70 | 93.35 | 95.74 | 92.77 | 0.631 times |
| 16 Fri Aug 2024 | 93.49 | 95.44 | 95.99 | 93.15 | 1.003 times |
| 15 Thu Aug 2024 | 95.52 | 95.60 | 96.21 | 94.33 | 0.9 times |
| 14 Wed Aug 2024 | 93.36 | 93.11 | 94.31 | 91.82 | 0.969 times |
| 13 Tue Aug 2024 | 92.82 | 94.43 | 95.39 | 91.55 | 1.143 times |
| 12 Mon Aug 2024 | 93.71 | 94.44 | 95.33 | 93.43 | 0.857 times |
| 09 Fri Aug 2024 | 93.90 | 91.80 | 94.70 | 90.74 | 1.191 times |
| 08 Thu Aug 2024 | 91.44 | 91.38 | 91.74 | 89.44 | 1.505 times |
My analysis of stock is bearish for shortterm, and stock might move down till 90.8 or till 81.9. Use a stoploss of 98.15 and if the stock hits stoploss, then it can shoot up till 105.53
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 84.33 |
| Downside Target | 89.35 |
| Upside Target | 95.50 |
| Upside Target | 100.67 |
| Upside Target | 106.56 |
| Upside Target | 108.40 |
| Upside Target | 111.02 |
| Upside Target | 111.42 |
| Upside Target | 112.02 |
| Upside Target | 112.64 |
| Upside Target | 118.91 |
| Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 93.08 |
| Downside Intraday Target | 91.39 |
| Upside Intraday Target | 96.16 |
| Upside Intraday Target | 97.55 |
| Downside Intraday Target | 94.47 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 21 Wed Aug 2024 | 94.78 | 93.35 | 95.85 | 92.77 | 0.405 times |
| 16 Fri Aug 2024 | 93.49 | 94.44 | 96.21 | 91.55 | 0.608 times |
| 09 Fri Aug 2024 | 93.90 | 90.00 | 95.91 | 89.35 | 0.68 times |
| 02 Fri Aug 2024 | 96.72 | 112.44 | 112.64 | 95.50 | 2.675 times |
| 26 Fri Jul 2024 | 112.19 | 116.25 | 118.91 | 112.02 | 0.705 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 21 Wed Aug 2024 | 94.78 | 106.51 | 108.40 | 89.35 | 0.975 times |
| 31 Wed Jul 2024 | 108.30 | 107.68 | 121.90 | 106.56 | 1.132 times |
| 28 Fri Jun 2024 | 107.78 | 106.43 | 111.42 | 100.67 | 0.902 times |
| 31 Fri May 2024 | 105.56 | 91.44 | 111.02 | 90.85 | 1.009 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 93.57 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 93.57 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.